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Of all the species exposed naturally to the bovine
spongiform encephalopathy (BSE) agent, the greater kudu
(Tragelaphus strepsiceros), a nondomesticated bovine
from Africa, appears to be the most susceptible to the dis-
ease. We present the results of mouse bioassay studies to
show that, contrary to findings in cattle with BSE in which
the tissue distribution of infectivity is the most limited
recorded for any of the transmissible spongiform
encephalopathies (TSE), infectivity in greater kudu with
BSE is distributed in as wide a range of tissues as occurs
in any TSE. BSE agent was also detected in skin, conjunc-
tiva, and salivary gland, tissues in which infectivity has not
previously been reported in any naturally occurring TSE.
The distribution of infectivity in greater kudu with BSE sug-
gests possible routes for transmission of the disease and
highlights the need for further research into the distribution
of TSE infectious agents in other host species.
T
o date, 13 species of zoo animal have been confirmed
as having died with a novel scrapie-like spongiform
encephalopathy (SE) concurrent with the bovine spongi-
form encephalopathy (BSE) epidemic (Table 1). The dis-
ease is thought, in some, if not all, of these species, to be
caused by infection with the BSE agent. In addition, natu-
ral infection with BSE has been reported in five species of
primate in French zoos (11), but these results are consid-
ered equivocal for the confirmation of a spongiform
encephalopathy (12, G.A.H. Wells, unpub. data). BSE was
diagnosed in six of eight greater kudu (Tragelaphus strep-
siceros), a member of the family Bovidae, subfamily
Bovinae, that died at the London Zoo from 1989 through
1992 (2,13,14). The epidemiology of this disease in greater
kudu is consistent with either a particularly high suscepti-
bility to infection, the occurrence of direct animal-to-ani-
mal transmission of the disease, or with a combination of
these factors (2,14,15). To investigate further the biology
of BSE in greater kudu, the distribution of the infectious
agent in greater kudu with BSE was determined by using
the mouse bioassay method.
Materials and Methods
Tissues
Tissues from four greater kudu that died with spongi-
form encephalopathy were tested for infectivity by bioas-
say in C57Bl-J6 mice (Table 2). The epidemiologic,
clinical, and pathologic findings of the disease in the kudu
have been described in detail previously (2,14–16), and a
summary of the relevant details is given in Table 3. Tissues
for bioassay were collected principally from kudu A1212;
each sample was collected in a sterile container by using
new disposable instruments and gloves to prevent cross
contamination between tissues. As TSE infectivity has
been demonstrated previously by bioassay in tissues pre-
served in formalin and paraffin wax (13,17,18), tissue
samples obtained opportunistically after routine post-
mortem examinations of three additional kudu (A664,
A666, and A1221) were also tested for infectivity by using
mouse bioassay. Samples collected from kudu A666,
A1212, and A1221 were stored in separate, sterile contain-
ers and were either frozen at –20°C or fixed in neutral
buffered 10% formalin. Non-neural tissues from kudu
A664 were fixed in neutral buffered 10% formalin in a
common container. The brain from this animal was the last
organ removed at necropsy and was fixed in 10% formol
saline in a separate container.
Previously, infectivity had been detected in formalin-
fixed brain tissue from kudu A664 by bioassay using five
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Kingdominbred mouse strains, with similar incubation periods and
lesion profiles to those demonstrated for the BSE agent
from domestic cattle with BSE (13). Bioassay of brain
from kudu A664 was not repeated in the current study, but
a positive control sample of fresh brain tissue from clini-
cally affected kudu A1212 was tested.
Bioassay
The tissues injected into mice for BSE-bioassay are list-
ed in Table 2. Most of the tissue homogenates were pre-
pared from thawed samples of fresh tissues frozen at
–20°C. Tissue homogenates prepared from formalin-fixed
tissues were rinsed overnight in running water to leach out
the fixative, while formalin-fixed, paraffin-embedded tis-
sues were dewaxed in chloroform (two changes) and
washed in several changes of absolute alcohol before being
rehydrated by immersion in a series of aqueous solutions
of descending concentrations of alcohol, through to 100%
water. Material for each tissue homogenate was dissected
from the center of each tissue sample by using single-use
disposable instruments and rigorous sterile procedures.
Each sample was homogenized in 10% physiologic saline
to make a 10% wt/vol suspension, which was then passed
through a gauze filter. To tissue homogenates containing
distal ileum or feces, ampicillin was added at the rate of
1.25 mg/mL. 
For each tissue homogenate, 20 C57Bl-J6 mice (4–7
weeks old) were each injected by the intracranial route
(0.02 mL) and by the intraperitoneal route (0.10 mL).
Single tissue or pooled tissue samples were prepared and
injected into C57Bl-J6 mice for a standard qualitative
assay of infectivity (13,19).
Mice injected with different tissue or tissue-pool
homogenates were housed in separate cages. Injected mice
were coded, and detailed clinical monitoring of the mice
was carried out by using a standard protocol. The clinical
endpoint was determined when mice either showed clear
signs of neurologic disease (20) or other deterioration of
health. Surviving mice were killed 950 days after injection.
Postmortem confirmation of disease in mice was routinely
carried out by histopathologic examination of the brain for
morphologic changes of spongiform encephalopathy.
After the histopathologic assessment of mice, immuno-
histochemical examination (IHC) for evidence of spongi-
form encephalopathy disease-specific PrP (PrPSc) was
performed on the brains of all mice in selected tissue
groups. The groups were mice in which either a low num-
ber were positive, testing was inconclusive on histopatho-
logic assessment, or the results indicated a novel or
anomalous distribution of the agent in kudu compared to
that in other TSE. Additional groups of interest (skeletal
muscle, endometrium, and mammary gland), which were
negative on the histopathologic examination of mouse
brains, were also examined by IHC. Immunohistochemical
detection of PrPSc was introduced to the standard protocol
to improve specificity and sensitivity of detecting BSE
transmission to mice (21,22) and interpret inconclusive
histopathologic results (23). For control purposes, the
brains from mice that had been injected with pathological-
ly affected cranial thoracic spinal cord from kudu A1212
were also immunostained. Brains from normal mice that
were not injected with infected tissues were similarly
examined to provide negative controls.
The immunohistochemical method used was essential-
ly that applied previously to cattle central nervous system
tissues (24) and adapted for use in mouse brain tissue.
Anti-bovine PrPSc serum (971) was used at 1/8,000 and
1/16,000 dilutions in an avidin-biotin-peroxidase (ABC)
complex technique. Transmission was defined by
histopathologic evidence of spongiform encephalopathy,
or, where applied, immunohistochemical presence of
disease-specific PrP (PrPSc) in the brains of the mice.
Results
The results of the bioassay of tissues are given in Table 2.
Based on the histopathologic examination of mouse brains,
15 of the 32 tissue homogenates were positive. The nine
histopathologically positive groups examined immunohis-
tochemically were confirmed positive by this method with
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Table 1. Species of zoo animal with confirmed novel spongiform 
encephalopathy acquired contemporaneously with epidemic of 
bovine spongiform encephalopathy in domestic cattle
a 
Species  No. of cases  Reference 
Bovidae     
Nyala, Tragelaphus angasi  1  1 
Greater kudu, Tragelaphus 
strepsiceros 
6  2 
Gemsbok, Oryx gazella  1  1 
Arabian oryx, Oryx leucoryx  1  3 
Scimitar-horned oryx, Oryx 
dammah 
1  2 
Eland, Taurotragus oryx  6  2,4 
American bison, Bison bison  1  5 
Felidae     
Cheetah, Acinonyx jubatus  10
b  2,5–8 
Puma, Felis concolor  3  2,9 
Ocelot, Felis pardalis  3  4,5 
Tiger, Panthera tigris  3  5 
Lion, Panthera leo  4  4,5 
Asian golden cat, Catopuma 
temminckii 
1
c  10 
aAnimals were born and cases occurred in Great Britain unless stated otherwise. 
b The initial case of transmissible spongiform encephalopathy in a cheetah 
occurred in Australia, one case in the Republic of Ireland, and three cases 
in France; all animals were born in Britain except the most recently reported 
case in France. 
cReported from Australia, born in Germany, and kept for a period in the 
Netherlands (10). marginal improved sensitivity of detection (2–3 more mice
positive) in only three groups. For nine of the positive tis-
sue homogenates, prepared from fresh central nervous,
lymphoreticular, or distal ileum tissue, the proportion of
positive mice (>40%) indicated moderate or high levels of
spongiform encephalopathy infectivity. The remaining six
positive groups (Table 2) had low proportions of positive
mice (6%–27%), indicative of relatively low titres or only
traces of infectivity. Low numbers (1–2) of histopatholog-
ically inconclusive mice in five tissue homogenate groups,
which included two groups (A1212, popliteal and sub-
mandibular lymph nodes) that contained no histopatholog-
ically positive mice, were resolved almost exclusively as
negative when examined using immunohistochemistry.
The one exception was an inconclusive mouse in A1212
retropharyngeal lymph node group, which proved
immunohistochemically positive. 
Discussion
Fifteen of the 32 kudu tissue homogenates transmitted
BSE to mice. The positive result for brain tissue from kudu
A1221 confirms the diagnosis of subclinical spongiform
encephalopathy in this animal (15) and is the first to
demonstrate transmission from a subclinical natural case
of spongiform encephalopathy in a bovine species. Also,
this report is the first of infectivity in the ileum from a field
case of spongiform encephalopathy other than scrapie in
sheep.
Apparently low titers or only traces of infectivity were
detected in spleen, lung, submandibular salivary gland,
conjunctiva, and skin. In bioassays of TSE infectivity, the
possibility that trace levels of infectivity in tissues may
represent postmortem or laboratory contamination of unin-
fected tissues with infected material has to be considered.
Such an explanation is unlikely in the present study for the
RESEARCH
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Table 2. Bioassay results for greater kudu tissues injected into C57Bl-J6 mice 
Kudu identification no.  Tissue
a injected 
Positive 
mice/total
b 
Mean survival period post 
injection (days) ± SD
c 
Survival period 
range (d)
c 
A1212  Rostral cerebrum  13/20  595±84  428–745 
  Cranial thoracic spinal cord  19/20
d  557±121  413–821 
  Lumbar spinal cord  15/19  521±69  432–634 
  Spleen  3/11
d  819±41  773–851 
  Retropharyngeal lymph node  6/11
d  784±77  691–921 
  Popliteal lymph node  0/20
d  N/A
e  N/A 
  Visceral lymph nodes (pool)  14/18  622±114  448–860 
  Submandibular lymph node  0/20
d  N/A  N/A 
  Distal ileum  11/20  547±98  426–718 
  Lung  1/14
d  N/A  746 
  Kidney  0/18  N/A  N/A 
  Caruncular endometrium  0/20
d  N/A  N/A 
  Ovary  0/20  N/A  N/A 
  Mammary gland  0/20
d  N/A  N/A 
  Submandibular salivary gland  1/17
d  N/A  599 
  Conjunctiva  1/16
d  N/A  659 
  Nasal mucosa  0/20  N/A  N/A 
 
Skeletal muscle  
(biceps brachii + vastus lateralis) 
0/19
d  N/A  N/A 
  Skin (flank)  2/18
d  713±22  697–728 
  Feces  0/11  N/A  N/A 
  Serum  0/19  N/A  N/A 
A664  Spleen (P)  1/8
d  N/A  929 
  Visceral lymph nodes (pool) (P)  6/15
d  843±113  649–952 
  Lung (P)  0/20  N/A  N/A 
  Kidney (P)  0/20  N/A  N/A 
  Skeletal muscle (P)  0/19  N/A  N/A 
A1221  Brainstem  10/18  634±62  541–762 
  Kidney  0/20  N/A  N/A 
  Skeletal muscle (vastus lateralis) (F)  0/19  N/A  N/A 
A1221 + A666 (pool)  Spleen (pool)  0/20  N/A  N/A 
  Visceral lymph nodes (pool)  10/18  700±108  455–851 
  Lung (pool) (F)  0/19  N/A  N/A 
aTissues not prepared fresh are suffixed: (F), fixed, (P), paraffin wax embedded. 
bNumber of mice positive/number of mice surviving when the first mouse was confirmed positive by histopathologic or immunochemical examination. The 
denominator for negative groups is the number of mice examined. 
cSurvival periods of positive mice determined positive either by histopathologic or immunohistochemical examination results. 
dMice examined by PrP
Sc immunohistochemical examinations. 
eN/A, not applicable. following reasons. Many of the tissues which contained
only traces of infectivity were taken from kudu A1212, an
animal from which tissues were collected by using rigor-
ous sterile procedures to prevent cross-contamination, and
no pattern between the order of tissue sampling and the
bioassay results from this animal suggests a sequence of
tissue contamination. A low incidence of disease in the
mice or failure to detect infectivity from tissues previous-
ly fixed or processed to paraffin wax may be attributable to
a reduced titer of infectivity, which can occur as a result of
such treatments. The wide range of survival periods for
positive mice in these assays (Table 2) is similar to those
seen when brain tissue from confirmed cases of BSE in
domestic cattle was injected into C57Bl-J6 mice of the
same source as used in the current study (G.A.H. Wells and
M. Dawson, unpub. data). These results contrast with those
from a previous study (13) in which 20 of 21 C57Bl mice
were positive for spongiform encephalopathy after injec-
tion of formalin-fixed brain from the index case of TSE in
greater kudu (kudu A664), with a mean incubation period
of 465±14 days (M. Bruce, pers. comm.). We conclude that
the low incidence of positive mice in certain tissue groups
is due to a lower titer of infectious agent within these tis-
sues when compared with the CNS or ileum.
The distribution of BSE infectivity in tissues of greater
kudu contrasts with that in tissues of BSE-infected cattle
(24,25) but is more like the distribution found in genetical-
ly susceptible sheep infected with scrapie or experimental
BSE (26–28). In field cases of cattle with BSE, infectivity
has been found only in the CNS (25), but in cattle experi-
mentally challenged orally with the agent of BSE, ileum
and bone marrow have also been shown to contain infec-
tivity (21,24,29). In classical studies of scrapie in sheep
and goats, infectivity was detected in the nervous and lym-
phoreticular systems, placenta, adrenal gland, nasal
mucosa, lung, pancreas, liver, bone marrow, thymus, and
alimentary tract, although most of the non-neural, non-
lymphoreticular peripheral tissues contained only low
titers of agent (30,31). 
The finding of infectivity in kudu skin, conjunctiva, and
submandibular salivary gland was unexpected as these tis-
sues have not been previously shown to be infective in
scrapie, BSE, or any naturally occurring TSE. Nonetheless,
infectivity has been found previously in salivary glands of
mice after injection of infected tissues with a high titer of
scrapie agent (32) and of mink injected with the transmissi-
ble mink encephalopathy agent (33). In experimentally-
induced transmissible mink encephalopathy, low
concentrations of agent occurred in liver, kidney, intestine,
and salivary gland only after replication in the CNS and in
some lymphoreticular tissues (33). The inconsistent obser-
vation of low levels or traces of infection in certain non-
neural and non-lymphoreticular tissues is in general a
feature of both natural and experimental TSE. Given the
relative paucity of data on the tissue distribution of infectiv-
ity in TSEs, the finding of infection in any given tissue
should probably not be regarded as surprising. The infectiv-
ity of a certain tissues subsequent to CNS involvement may
be a rare event incidental to the pathogenesis of the disease. 
We have previously indicated that the epidemiology of
BSE in the small kudu herd at London Zoo was consistent
with either a particularly high susceptibility to infection,
the occurrence of direct animal-to-animal transmission of
the disease, or with a combination of these factors
(2,14,15). The presence of infectivity in tissues, such as the
skin and salivary gland, suggests possible routes by which
direct transmission could occur. Eklund et al. (32), for
example, suggested infection of the salivary gland as an
explanation for contact infection of scrapie between mice. 
Given the extended survival period range with BSE in
the C57Bl-J6 mice used in the current study compared to
the incubation periods in C57Bl mice used previously (13)
and the relative insensitivity of the mouse model (24), these
results may be an underestimate of the extent of infectivity
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Table 3. Details of spongiform encephalopathy–positive greater kudu used for mouse inoculation studies 
Kudu ref no. 
Age at 
death (mo)  Sex  Brief history  Basis of diagnosis 
A664  30  F  Born at London Zoo. Died after progressive 
neurologic disease of approximately 72 hours. 
Examined postmortem on the same day. 
Histopathologic examination of brain and 
experimental transmission to mice 
A666  37  M  Born at London Zoo. Killed after progressive 
neurologic disease of approximately 24 hours. 
Examined postmortem on the same day. 
Histopathologic, SAF, and PrP
Sc 
immunocytochemical examinations of the 
brain and spinal cord
a 
A1221  18  M  Born at London Zoo. Killed for management 
reasons as a clinically healthy animal and 
immediately examined postmortem. 
Histopathologic, SAF, and PrP
Sc 
immunocytochemical examinations of the 
brain and spinal cord 
A1212  39  F  Born in Britain, moved to London Zoo at 12 months 
of age. Killed following progressive neurologic 
disease lasting approximately 1 month and 
immediately examined postmortem. 
Histopathologic and SAF examinations of 
the brain 
aSAF, scrapie-associated fibrils; PrP
Sc, transmissible spongiform encephalopathy disease-specific form of the PrP protein. in the kudu tissues assayed. A recently reported rapid
immunoassay shown to be capable of detecting PrPBSE in
the brainstems of cattle with a sensitivity similar to that of
the infectivity levels determined by end-point titration in
Tg(BoPrP) mice (34) possibly offers prospects for more
sensitive detection of disease-related PrP as a proxy for
infectivity bioassay. An important area for further research,
therefore, is to investigate whether our results represent true
qualitative differences in the biology of BSE in the greater
kudu and the domestic cow or possibly indicate similarities,
unapparent only because of the variables inherent in the
sensitivities of current bioassay methods.
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